| OAC0304 | Initiation of pre-exposure prophylaxis (PrEP) among key populations in PEPFAR-supported countries during 2019–2022 | Oral abstract session with live Q&A | HIV prevention research |
| OALBX0203 | Initial PrEP product choice: results from the HPTN 084 open-label extension | Oral abstract session with live Q&A | HIV prevention research |
| LBEPD37 | Inhaled nitrite abuse and quitting attention among men who have sex with men in China: a theory of planned behavior-informed study | E-poster | Social science theories, concepts and methods |
| EPB0288 | Influence of the COVID-19 pandemic in the rate of viral suppression of people living with HIV in Mexico under antirretroviral therapy | E-poster | SARS-CoV-2, COVID-19 and HIV |
| EPB0283 | Influence of SARS-COV-2 on coagulation and cardiovascular plasma biomarkers in people living with HIV | E-poster | SARS-CoV-2, COVID-19 and HIV |
| MOPEA04 | Infection by high replication capacity HIV-1 viruses is associated with increased glucose metabolism by T cells | Poster exhibition | HIV pathogenesis |
| EPC0392 | Indications, adherence and outcomes of HIV Post-Exposure Prophylaxis (PEP) among users in military health facilities in Uganda | E-poster | HIV prevention research |
| EPC0468 | Index testing strategy optimizes HIV case finding among men in five Nigerian states, moving country closer to epidemic control | E-poster | HIV testing |
| MOPEE01 | Index case contact testing to improve HIV case identification in the community settings of Ethiopia | Poster exhibition | Implementation science and scale up of HIV testing |
| LBEPA07 | In-depth characterization of functional anti-Env antibody responses during early or late viral suppression with fostemsavir in treatment-experienced patients | E-poster | Host immune responses, vaccines and immunotherapies |